{"id":5542,"date":"2017-06-30T13:51:00","date_gmt":"2017-06-30T13:51:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5542"},"modified":"2021-07-12T07:59:51","modified_gmt":"2021-07-12T07:59:51","slug":"long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/","title":{"rendered":"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Iizuka+M&amp;cauthor_id=28924114\">Masahiro Iizuka<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-1\">1<\/a>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Etou+T&amp;cauthor_id=28924114\">Takeshi Etou<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-2\">2<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kumagai+M&amp;cauthor_id=28924114\">Makoto Kumagai<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Matsuoka+A&amp;cauthor_id=28924114\">Atsushi Matsuoka<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Numata+Y&amp;cauthor_id=28924114\">Yuka Numata<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-3\">3<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sagara+S&amp;cauthor_id=28924114\">Shiho Sagara<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/#affiliation-1\">1<\/a><\/sup> , Intern Med. 2017 Oct 15;56(20):2705-2710.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Conclusion We confirmed that LI-CAP has therapeutic effects on reducing the dosage and discontinuing steroids in patients with steroid-dependent UC.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5675930\/pdf\/1349-7235-56-2705.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5675930\/pdf\/1349-7235-56-2705.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Masahiro Iizuka&nbsp;1&nbsp;2,&nbsp;Takeshi Etou&nbsp;2,&nbsp;Makoto Kumagai&nbsp;3,&nbsp;Atsushi Matsuoka&nbsp;3,&nbsp;Yuka Numata&nbsp;3,&nbsp;Shiho Sagara&nbsp;1 , Intern Med. 2017 Oct 15;56(20):2705-2710. Conclusion We confirmed that LI-CAP has therapeutic effects on reducing the dosage and discontinuing steroids in patients with steroid-dependent UC. https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5675930\/pdf\/1349-7235-56-2705.pdf<\/p>\n","protected":false},"template":"","scientific_tags":[309,354,55,306],"class_list":["post-5542","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-steroid-free","scientific_tags-steroid-sparing","scientific_tags-steroid-dependent","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy\u3000leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Masahiro Iizuka&nbsp;1&nbsp;2,&nbsp;Takeshi Etou&nbsp;2,&nbsp;Makoto Kumagai&nbsp;3,&nbsp;Atsushi Matsuoka&nbsp;3,&nbsp;Yuka Numata&nbsp;3,&nbsp;Shiho Sagara&nbsp;1 , Intern Med. 2017 Oct 15;56(20):2705-2710. Conclusion We confirmed that LI-CAP has therapeutic effects on reducing the dosage and discontinuing steroids in patients with steroid-dependent UC. https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5675930\/pdf\/1349-7235-56-2705.pdf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy\u3000leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:59:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/\",\"name\":\"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2017-06-30T13:51:00+00:00\",\"dateModified\":\"2021-07-12T07:59:51+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy\u3000leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/","og_locale":"es_ES","og_type":"article","og_title":"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte","og_description":"Masahiro Iizuka&nbsp;1&nbsp;2,&nbsp;Takeshi Etou&nbsp;2,&nbsp;Makoto Kumagai&nbsp;3,&nbsp;Atsushi Matsuoka&nbsp;3,&nbsp;Yuka Numata&nbsp;3,&nbsp;Shiho Sagara&nbsp;1 , Intern Med. 2017 Oct 15;56(20):2705-2710. Conclusion We confirmed that LI-CAP has therapeutic effects on reducing the dosage and discontinuing steroids in patients with steroid-dependent UC. https:\/\/pubmed.ncbi.nlm.nih.gov\/28924114\/ https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5675930\/pdf\/1349-7235-56-2705.pdf","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy\u3000leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:59:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/","name":"Long-interval Cytapheresis as a Novel Therapeutic Strategy\u3000Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2017-06-30T13:51:00+00:00","dateModified":"2021-07-12T07:59:51+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/long-interval-cytapheresis-as-a-novel-therapeutic-strategy%e3%80%80leading-to-dosage-reduction-and-discontinuation-of-steroids-in-steroid-dependent-ulcerative-colitis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5542"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}